Loading...
•
Nov 30, 2020
AngioDynamics Q2 2021 Earnings Report
Reported a revenue increase driven by sales execution and expense management, resulting in positive earnings.
Key Takeaways
AngioDynamics reported a 4.0% increase in net sales to $72.8 million compared to the prior-year quarter. The company's gross margin declined to 55.2%, and GAAP loss per share was $0.11, while adjusted earnings per share was $0.01. They reaffirmed their fiscal year 2021 net sales guidance between $278 and $284 million and adjusted earnings per share between $0.00 and $0.05.
Net sales increased 4.0% compared to the prior-year quarter, reaching $72.8 million.
Gross margin declined 410 basis points year over year to 55.2%.
GAAP loss per share was $0.11, while adjusted earnings per share was $0.01.
Cash and cash equivalents were $58.0 million, compared to $47.9 million on August 31, 2020.
Revenue by Geographic Location
Forward Guidance
The Company continues to expect fiscal year 2021 net sales in the range of $278 to $284 million and fiscal year 2021 adjusted earnings per share in the range of $0.00 to $0.05.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...